What is IDX?
Founded in 2010, IDX operates at the intersection of clinical science and machine learning. The company specializes in the development of autonomous algorithms designed to identify pathologies within medical imagery. Its flagship product, IDx-DR, represents a significant milestone in digital health, having secured FDA clearance for the detection of diabetic retinopathy and macular edema. By decentralizing diagnostic assessment and moving it into primary care environments, IDX is effectively lowering barriers to high-quality disease detection. The firm's current pipeline includes advanced diagnostic systems targeting macular degeneration, glaucoma, stroke risk, and various ear infections, positioning it as a critical player in the future of preventative medicine and AI-driven diagnostics.
How much funding has IDX raised?
IDX has raised a total of $40M across 4 funding rounds:
Private Equity
$1.4M
Private Equity
$1.1M
Private Equity
$4.5M
Series A
$33M
Private Equity (2012): $1.4M, investors not publicly disclosed
Private Equity (2012): $1.1M, investors not publicly disclosed
Private Equity (2013): $4.6M, investors not publicly disclosed
Series A (2018): $33M, investors not publicly disclosed
Key Investors in IDX
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for IDX?
With the recent influx of capital, IDX is well-positioned to accelerate its research and development initiatives. The company is expected to focus on expanding its regulatory footprint and broadening the clinical utility of its autonomous diagnostic platform. As the healthcare industry shifts toward value-based care models, IDX's ability to provide scalable, cost-effective diagnostic tools will likely serve as a primary growth driver. Future strategic efforts will likely involve deepening integration with existing electronic health record systems and pursuing additional FDA clearances to address a wider spectrum of chronic conditions, thereby cementing its role as a foundational technology provider in the global healthcare ecosystem.
See full IDX company page
